Rheumatology and Immunology Flashcards
MC type of Arthritis
OA - MCC of chronic knee pain in persons >45 y/o
pathologic sine qua non of OA
hyaline articular cartilage loss
usually SPARED joints in OA
AWE
ankle
wrist
elbow
1st line treatment in OA
NSAIDs and COX 2 inhibitor
Laboratory seen in OA and RA
OA: WBC <2000
RA: 5000-50,000; overwhelming neutrophil
Radiographic seen in OA and RA
OA: joint space loss or narrowing, osteophytes
RA: periarticular osteopenia (early) soft tissue swelling, joint space loss, subchondral erosion
This is a flexion of the PIP joint with hyperextension of the DIP joint
Boutonniere deformity
Hyperextension of the PIP joint with a flexion of DIP joint
Swan-neck deformity
Subluxation of the 1st MCP joint with hyperextension of 1st IP joint
Z line deformity
hallmark of the RA
Flexor tenosynovitis (trigger fingers)
MC pulmonary manifestation of RA
Pleuirits
MC valvular abnormality in RA
MR
Conditions with positive RF
SLE
Sjogren syndrome
subacute bacterial endocarditis
Hepatitis B and C
first choice for the early treatment of RA
MTX with Folic Acid
— MTX is a folate antagonist
DMARD given to Pregnant
Hydrochloroquine
Sulfasalazine
Conventional DMARD
Hydroxychloroquine
Sulfasalazine
MTX
Leflunomide
no adequate response to MTX
within 6mos, step up –> triple therapy:
MTX, Sulfasalazine, Hydroxychloroquine
Diuretic drugs that decrease renal excretion of the uric acid
Thiazides
Clinical features seen in OA
Bouchard (PIP) and Heberden (DIP) Nodes
Triad of Felty syndrome
nodular RA
neutropenia
Splenomegaly
MC used HYPOURECEMIC agent
Allopurinol
DIP of pencil-in-cup deformity
Psoriatic arthritis
MC CHRONIC DERMATITIS in lupus
Discoid Lupus erythematous
MC acute SLE rash
Butterfly rash
Labtest should be monitored every 12 weeks
Creatinine
CBC - myelosuppresion
Antibodies specific for SLE
anti- dsDNA – correlate with Disease activity: nephritis, vasculitits
anti-Smith
Drug induced lupus
Lupus Makes My HIPS Extremely Painful
Methyldopa
Minocycline
Hydralazine
Isoniazid
Phenytoin
Sulfa drugs
Etanercept
Procainamide
antibodies seen in Drug-induced lupus
Anti-histone
mainstay treatment in SLE
Systemic Glucocorticoids
Most serious cardiac manifestation in SLE
Myocarditis
Libman-Sacks endocarditis
best screening test for SLE
ANA antibody
most accurate test in Sjogren syndrom
Labial biopsy
MC site of urticaria
extremities and face
MC site for angioedema
periorbital and lips
most potent drug for the treatment of rhinitis
intranasal glucocorticoid (high dose)
DOC for the 1st prevention of ARF
benzathine Pen G 1.2M
Penicillin/Amoxicillin Po for 10 days
Drugs for secondary prevention
Benzathine Pen G 1.2M every 4 weeks
Oral Pen V 250mg BID
Erythromycin (penicillin allergy) 25mg BID
DUration of Prophylaxis in patient with RF without carditis
5 yrs last attack until 21 y/o
Duration of Prophylaxis in patient with RF with carditis without valvular dse
10 yrs last attack until 21 y/o
DUration of Prophylaxis in patient with RF with carditis and persistent valvular disease
10 yrs last attack until 40 y/o or sometimes lifetime
Diagnosis of the RECURRENT ARF
2 major
1 major and 2 minor
3 minor
Diagnosis of the INITAL ARF
2 major
1 major + 2 minor
TOC for Anaphylaxis
Epinephrine 0.3-0.5mL of 1:1000 (1mg/ml) IM with repeated dose at 5-20mins interval for severe reaction